Recruiting OBSERVATIONAL NCT05434325

TESTING -ON Post-Trial ObservatioNal Cohort Study (TESTING-ON)

Therapeutic Evaluation of STeroids in IgA Nephropathy Global - Post-Trial ObservatioNal Cohort Study

Sponsor: Peking University Institute of Nephrology

Conditions ESRD Glomerulonephritis IgA Nephropathy Kidney Diseases

Updated 6 times since 2022 Last updated: Feb 9, 2025 Started: Dec 7, 2022 Primary completion: Jul 30, 2027 Completion: Jul 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05434325, this observational or N/A phase trial focuses on ESRD and Glomerulonephritis and remains actively recruiting participants. Sponsored by Peking University Institute of Nephrology, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Mar 2025 — Present [monthly]

Recruiting
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Feb 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Feb 2023 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Jul 2022 — Sep 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University Institute of Nephrology
The George Institute

Data source: The George Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Baotou, China , Beijing, China , Calgary, Canada , Chandigarh, India , Changchun, China , Chen, India , Chengdu, China , Chongqing, China , Dalian, China and 31 more locations